A study performed at the Italian Piemonte University and published in 2008 implied that all cannabinoids help the immune system to fight bacteria. Especially potent are five cannabinoids (including CBD), with the study focusing on antibiotic-resistant strains of the Staphylococcus Aureus, a relevant example of the antibiotics abuse the last few decades have witnessed.
Relevant studies are summarized in Table Table3.3. In a SPECT study of resting cerebral blood flow (rCBF) in normal subjects, CBD reduced rCBF in left medial temporal areas, including the amygdala and hippocampus, as well as the hypothalamus and left posterior cingulate gyrus, but increased rCBF in the left parahippocampal gyrus. These rCBF changes were not correlated with anxiolytic effects . In a SPECT study, by the same authors, in patients with SAD, CBD reduced rCBF in overlapping, but distinct, limbic and paralimbic areas; again, with no correlations to anxiolytic effects .
Anxiolytic effects in models used: CER = reduced fear response; CFC = reduced conditioned freezing; CFC extinction = reduced freezing following extinction training; EPM = reduced % time in open arm; ETM = decreased inhibitory avoidance; L-DT = increased % time in light; VCT = increased licks indicating reduced conflict; NSF = reduced latency to feed; OF = increased % time in center; SI = increased social interaction
Cannabis also has links to Christianity – specifically through the Ethiopian Coptic Church, which is held to have been established by St. Mark (the guy in the New Testament of The Bible) in AD 45. The Copts claim that the use of marijuana as a sacrament descended from a Jewish sect called the Essenes (the folks who wrote the Dead Sea Scrolls). According to the Coptic Church, cannabis played an important role in early Christian and Judaic rituals, specifically as a sacrament burned in tabernacles, to commemorate important occasions such as communication with God on Mount Sinai by Moses, and the transfiguration of Christ.
At the federal level, CBD is classified as a Schedule 1 drug in the U.S. because it is one of the many cannabinoids present in marijuana. To be labeled a schedule 1 drug means that it has a high potential for abuse and the potential to create severe psychological or physical dependence; therefore these drugs are not allowed to be used for medical use.
Last year, the National Academies of Sciences, Engineering and Medicine released a nearly 500-page report on the health effects of cannabis and cannabinoids. A committee of 16 experts from a variety of scientific and medical fields analyzed the available evidence — more than 10,000 scientific abstracts in all. Because so few studies examine the effects of CBD on its own, the panel did not issue any findings about CBD specifically, but it did reach some conclusions about cannabis and cannabinoids more generally. The researchers determined that there is “conclusive or substantial evidence” supporting the use of cannabis or cannabinoids for chronic pain in adults, multiple sclerosis-related spasticity (a kind of stiffness and muscle spasms), and chemotherapy-induced nausea and vomiting. The committee also found “moderate” evidence that cannabis or cannabinoids can reduce sleep disturbances in people with obstructive sleep apnea, fibromyalgia, chronic pain and multiple sclerosis, as well as “limited” evidence that these substances can improve symptoms of Tourette’s syndrome, increase appetite and stem weight loss in people with HIV/AIDs, and improve symptoms of PTSD and anxiety.
If you have a nervous or misbehaving pet, you may be at a loss when it comes to how to help them. Anxiety in dogs can be extremely hard to treat — after all, it’s not like you can have a conversation with your dog to find out what is wrong or how you might be able to help. However, you may have seen CBD making headlines as of late. What is CBD used for when it comes to pets? The answer may surprise you!
CBD oil works by activating the vanniloid (TRPV1), adenosine, and serotonin receptors in your body. It is the initiation of adenosine receptors that provides an anti-anxiety and anti-inflammatory result. It is also causes the release of dopamine and glutamate, two neurotransmitters that play major roles inside the body and are involved in feelings of well being.
Most human studies of CBD have been done on people who have seizures, and the FDA recently approved the first CBD-based drug, Epidiolex, for rare forms of epilepsy. Clinical trials for other conditions are promising, but tiny. In one Brazilian study published in 2011 of people with generalized social anxiety disorder, for example, taking a 600-mg dose of CBD (higher than a typical dose from a tincture) lessened discomfort more than a placebo, but only a dozen people were given the pill.
The article is inaccurate. CBD oil is not mutually exclusive from hemp oil, nor is all hemp made from industrial hemp. The hemp for NatureCBD is organically grown, and the word industrial, while having a negative connotation in this industry because of the fact it implies the oil is dirty, only means to classify that the hemp is grown for production (hemp fibers, basts etc). The oil in NatureCBD is indeed CBD oil, and always has a CBD content above 30%. The only thing that separates NatureCBD from being medical marijuana oil is the high CBD content and low THC content (below 0.01%).
The disturbing problem regarding the current status of cannabidiol is expressed in the same source. Institutional endeavors by the Food and Drug Administration to classify it as a drug are in its infancy. Nevertheless, this should mean that CBD could no longer be marketed as a dietary supplement, as that class of products is subject to ridiculously lax regulation. However, there are countless companies (some no larger than a newsstand, while others are listed on the stock exchange) that sell supplements containing cannabidiol (as oil, capsules, sprays, etc.) unencumbered by either state or federal authorities.
For people who suffer from insomnia, constant anxiety during the night or simply struggle to get a sound, restful night of undisturbed sleep, cannabis sativa essential oil may work like a charm. However, according to a research report published by Dr. Ethan Russo, Director of Research for the International Cannabis and Cannabinoids Institute, terpenoids produce an “entourage effect”.